首页 >
法规速递
-
Page: Guideline on quality aspects of mRNA vaccines for veterinary use-2026/2/20
2026-02-27查看详情 > -
Page: ICH Q2(R2) Validation of analytical procedures - Scientific guideline-2026/2/20
2026-02-27查看详情 > -
Document: Draft guideline on quality aspects of mRNA vaccines for veterinary use-2026/2/20
2026-02-27查看详情 > -
Page: Risk management requirements for elemental impurities in veterinary medicinal products - Scientific guideline-2026/2/20
2026-02-27查看详情 > -
Document: Data access to medicinal products for human use - Chapter 5 Annex A: Product data elements accessible by stakeholder group-2026/2/19
2026-02-27查看详情 > -
Document: Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026-2026/2/19
2026-02-27查看详情 > -
Document: Agenda of the CAT meeting 18-20 February 2026-2026/2/18
2026-02-27查看详情 > -
Page: Podcast: Inside EMA-2026/2/18
2026-02-27查看详情 > -
Document: Vaccine Monitoring Platform: List of EMA-funded studies-2026/2/18
2026-02-27查看详情 > -
Document: Scientific advice and protocol assistance adopted during the CHMP meeting 26-29 January 2026-2026/2/17
2026-02-27查看详情 >